DyssomniaNN: Multi-Scale Spiking Neural Modeling of Human Sleep Disorders and Perceived Restedness
Organizations: Department of Computer Science University of Wisconsin–Whitewater
Abstract
Clinical sleep medicine repeatedly documents profound divergences between objective sleep duration and subjective daytime impairment, notably exemplified by sleep state misperception in paradoxical insomnia and boundary instability in narcolepsy type 1. Here, we present DyssomniaNN: a multi-scale biophysical computational framework coupling Borbély's two-process regulation of sleep homeostasis and circadian drive with Saper's hypothalamic reciprocal flip-flop circuit and a recurrent corticothalamic leaky integrate-and-fire spiking neural network. We formalize five clinical cohorts across an identical 72-hour photoperiod: healthy control, circadian rhythm sleep-wake disorder (delayed-phase), chronic insomnia, paradoxical insomnia, and narcolepsy type 1. The synthetic local field potential converges closely with empirical human electroencephalography spectra from the PhysioNet Sleep-EDF database across all canonical frequency bands (spectral mean absolute error of 0.33--0.35). Furthermore, we introduce the Well-Rested Index to quantify restorative efficacy. Simulations reveal that sleep duration fails to predict restorative recovery: paradoxical insomnia achieves normal total sleep time (21.15 h) yet yields low restoration (37.6%) from unsuppressed cortical beta-band intrusion, whereas hypocretin deficiency in narcolepsy produces severe nocturnal fragmentation (781 min of wake after sleep onset) and 35 sleep-onset rapid eye movement periods. DyssomniaNN provides an in silico platform for mechanistic sleep research and virtual neuropharmacology.
Figures & tables
| Biophysical Parameter | Normal | CRSWD | Chronic Insomnia | Paradoxical | Narcolepsy |
|---|---|---|---|---|---|
| Phase Offset (h) | |||||
| Circadian Amplitude | |||||
| Orexin Tone | |||||
| Arousal Bias (pA) | |||||
| VLPO Inhibitory Weight | |||||
| Cortical Inh. Scale |
| Cohort | Sleep% | TST | SOL | WASO | Cycles | SOREMPs | Rested% | Rest Status | Spectral MAE |
|---|---|---|---|---|---|---|---|---|---|
| (Env) | (h) | (min) | (min) | (vs PhysioNet) | |||||
| Normal Control | Optimal | ||||||||
| CRSWD (Delayed) | Phase-Shifted | ||||||||
| Chronic Insomnia | Fragmented | ||||||||
| Paradoxical Insomnia | Non-Restorative | ||||||||
| Narcolepsy Type 1 | Fragmented |
Appendix figures & tables2 assets
Supplementary material from the paper’s appendix.
Appendix
| Abbr. | Full Term | Domain/Description |
|---|---|---|
| AASM | American Academy of Sleep Medicine | Clinical scoring standard organization |
| AMPA | -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | Fast excitatory ionotropic glutamate receptor |
| ATP | Adenosine Triphosphate | Cellular metabolic energy currency |
| CRSWD | Circadian Rhythm Sleep-Wake Disorder | Intrinsic circadian timing pathology |
| CSF | Cerebrospinal Fluid | Clear fluid surrounding brain and spinal cord |
| DLMO | Dim Light Melatonin Onset | Gold-standard circadian phase biomarker |
| Chemical | Class & Receptors | Anatomical Projections | Primary Functional Role |
|---|---|---|---|
| GABA | Amino Acid (ionotropic ) (metabotropic ) | VLPO, basal forebrain, local cortical interneurons | Primary central nervous system inhibitory neurotransmitter. Hyperpolarizes target neurons, gates slow-wave sync, and inhibits ascending monoamines to initiate sleep. |
| Galanin | Neuropeptide GalR1, GalR2, GalR3 ( ) | Co-localized with GABA in VLPO neurons | Co-released with GABA; provides sustained slow inhibition onto orexinergic and monoaminergic wake systems to maintain sleep continuity. |
| Orexin/ Hypocretin | Neuropeptide OX1R ( ), OX2R ( ) | Lateral hypothalamus (LHA) to brainstem, cortex, and thalamus | Essential wakefulness stabilizer. Projects excitatory drive to monoaminergic nuclei, reinforcing flip-flop hysteresis and preventing cataplexy/SOREMPs. |
| Glutamate | Amino Acid AMPA, NMDA, Kainate, mGluRs | Cortical pyramidal cells, thalamic relay, parabrachial nucleus | Primary fast excitatory neurotransmitter. Mediates cognitive processing, intracortical communication, and ascending reticular arousal drive. |
| Acetylcholine (ACh) | Quaternary Amine Muscarinic ( – ), Nicotinic | Basal forebrain, PPT/LDT brainstem nuclei | Desynchronizes cortical EEG. Active during waking cognition and elevated during REM sleep; quiescent during deep N3 slow-wave sleep. |
| Noradrenaline/ Norepinephrine | Monoamine adrenergic | Locus coeruleus (LC) to neocortex, thalamus, spinal cord | Mediates vigilance, environmental alertness, and stress responses. Discharges rapidly during wakefulness; quiescent during NREM and silent during REM sleep. |